BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AFSSI Sciences de la Vie - ECPv5.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AFSSI Sciences de la Vie
X-ORIGINAL-URL:https://www.afssi.fr
X-WR-CALDESC:Events for AFSSI Sciences de la Vie
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180312
DTEND;VALUE=DATE:20180315
DTSTAMP:20260604T033518
CREATED:20171005T123651Z
LAST-MODIFIED:20171005T172140Z
UID:1407-1520812800-1521071999@www.afssi.fr
SUMMARY:BIO-Europe Spring® 2018
DESCRIPTION:15\,000+ one-to-one partnering meetings\n3\,500+ licensing opportunities to access\n2\,600+ international executives from biotech\, pharma\, and finance\n1\,500+ companies representing 50+ countries\n120 biotech\, pharmaceutical\, next generation and academic innovator presentations\n70 C-level speakers on plenary sessions and business development workshops\n65 exhibitors in the high-traffic heart of the conference
URL:https://www.afssi.fr/event/bio-europe-spring-2018/
LOCATION:RAI Convention Center\, Amsterdam\, Pays-Bas
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/jpeg:https://www.afssi.fr/wp-content/uploads/2017/10/event-bio-europe-spring-bes-2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180313
DTEND;VALUE=DATE:20180315
DTSTAMP:20260604T033518
CREATED:20171123T181844Z
LAST-MODIFIED:20171123T181844Z
UID:3697-1520899200-1521071999@www.afssi.fr
SUMMARY:EPIGEN 2018 - ADEBIOTECH
DESCRIPTION: Place de l’épigénétique dans la réponse du vivant aux facteurs environnementaux\nPlus de détails sur www.adebiotech.org/epigen/
URL:https://www.afssi.fr/event/epigen-2018-adebiotech/
LOCATION:Biocitech Romainville\, 102 Avenue Gaston Roussel\, Romainville\, 93230\, France
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/jpeg:https://www.afssi.fr/wp-content/uploads/2017/11/event-epigen-adebiotech-2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180313
DTEND;VALUE=DATE:20180315
DTSTAMP:20260604T033518
CREATED:20180302T082343Z
LAST-MODIFIED:20180302T082343Z
UID:5001-1520899200-1521071999@www.afssi.fr
SUMMARY:2nd Annual Next Gen Immuno-Oncology Congress
DESCRIPTION:The current revolution in immuno-oncology is being driven by Antibody Drug Conjugates\, Immune Checkpoint Inhibitors\, Bispecific Antibodies and Cell Therapies. Clinical trials have shown that cancer patients can tolerate this immune-based treatment more effectively than conventional treatments like chemotherapy and radiotherapy. It’s clearly one of the hottest field of Biopharma which has gained momentum in the past few years. \nFollowing the success of our inaugural event\, MarketsandMarkets is proud to announce the 2nd Annual Next Gen Immuno-Oncology Congress to be held on 13th and 14th March 2018  at the Thistle  London Heathrow Terminal 5 in London\, UK. The congress aims to bring academicians\, researchers and scientists from research institutespharmaceutical\, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADC’s\, Bispecific Antibodies and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies\, pre-clinical and translational immune-oncology developments\, updates in cellular and viral therapies\, vaccines development and personalized immunotherapy. Keynote presentations\, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.
URL:https://www.afssi.fr/event/2nd-annual-next-gen-immuno-oncology-congress/
LOCATION:Londres\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://www.afssi.fr/wp-content/uploads/2018/03/london.jpg
END:VEVENT
END:VCALENDAR